User profiles for G. Ross

Gregory A. Ross

Research Leader, Isomorphic Labs
Verified email at isomorphiclabs.com
Cited by 2571

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

…, C Marras, CM Tanner, GW Ross… - Movement …, 2017 - Wiley Online Library
This article reviews and summarizes 200 years of Parkinson's disease. It comprises a relevant
history of Dr. James Parkinson's himself and what he described accurately and what he …

Tracking of sedentary behaviours of young people: a systematic review

SJH Biddle, N Pearson, GM Ross, R Braithwaite - Preventive medicine, 2010 - Elsevier
OBJECTIVE: To review the empirical evidence concerning the strength of tracking of sedentary
behaviours from childhood and adolescence. METHODS: Published English language …

Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue?

…, A Grandinetti, D Reed, LR White, GW Ross - Neurology, 1995 - AAN Enterprises
Article abstract—We reviewed 46 published reports associating cigarette smoking and
Parkinson's disease. Although the majority indicated an approximate halving of smoking …

Measurement of the intrinsic properties of materials by time-domain techniques

AM Nicolson, GF Ross - IEEE Transactions on instrumentation …, 1970 - ieeexplore.ieee.org
In this paper a method is presented for determining the complex permittivity and permeability
of linear materials in the frequency domain by a single time-domain measurement; typically…

[PDF][PDF] THE ROLE OF TUTORING IN PROBLEM SOLVING*

D Wood, JS Bruner, G Ross - Journal of child psychology and …, 1976 - elearning.auth.gr
THIS PAPER is concerned with the nature of the tutorial process; the means whereby an adult
or" expert" helps somebody who is less adult or less expert. Though its aim is general, it is …

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a …

…, G Bianchi, T Szado, J Ratnayake, G Ross… - The lancet …, 2012 - thelancet.com
Background Studies with pertuzumab, a novel anti-HER2 antibody, show improved efficacy
when combined with the established HER2-directed antibody trastuzumab in breast cancer …

[HTML][HTML] Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer

…, A Knott, E Clark, MC Benyunes, G Ross… - … England Journal of …, 2012 - Mass Medical Soc
Background The anti–human epidermal growth factor receptor 2 (HER2) humanized monoclonal
antibody trastuzumab improves the outcome in patients with HER2-positive metastatic …

[HTML][HTML] Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients …

…, JH Seo, YF Tsai, J Ratnayake, V McNally, G Ross… - Annals of oncology, 2013 - Elsevier
Background Pertuzumab (P) combined with trastuzumab (H)-based chemotherapy improves
efficacy in early and advanced HER2-positive breast cancer. We assessed the tolerability, …

Rotenone, paraquat, and Parkinson's disease

CM Tanner, F Kamel, GW Ross… - Environmental …, 2011 - ehp.niehs.nih.gov
Background Mitochondrial dysfunction and oxidative stress are pathophysiologic mechanisms
implicated in experimental models and genetic forms of Parkinson’s disease (PD). Certain …

[HTML][HTML] Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer

…, S Heeson, E Clark, G Ross… - New England journal …, 2015 - Mass Medical Soc
Background In patients with metastatic breast cancer that is positive for human epidermal
growth factor receptor 2 (HER2), progression-free survival was significantly improved after first-…